The purpose of this study was to evaluate the effectiveness of sandalwood oil for cutaneous viral warts caused by human papillomavirus. Sandalwood oil was applied topically twice daily for 12 weeks to cutaneous warts on any area of the body. Data collected at each visit included measurement of wart size, photograph of the warts, and documentation of treatment compliance and any adverse reactions. Ten subjects were enrolled and received treatment. At the end of the study, 8 of 10 (80%) had complete resolution of all treated warts. The remaining 2 subjects had improvement rated as moderate (25% to >90%). There were no complaints of skin irritation, erythema, itching, peeling of skin or scarring, pain or discomfort, or other adverse events reported. Sandalwood oil appears to be effective in the painless treatment of cutaneous warts caused by human papillomavirus.
Warts are among the more common skin lesions affecting humans. More than 200 subtypes of the human papillomavirus (HPV) have been identified as causal agents for common warts, and they have a variety of clinical presentations. They have been frustrating to treat, with variable success for most accepted therapies. Many complementary and alternative remedies have been suggested for removing warts. Sandalwood oil has been used for centuries as an herbal treatment for a variety of inflammatory skin conditions. More recently it has been examined as a potential treatment for skin papillomas.
Dwivedi and Abu-Ghazaleh 1 and Dwivedi and Zhang 2 reported the effects of sandalwood oil on skin papillomas in mice. A 2-stage skin tumor protocol was used to promote skin papillomas. 3 Sandalwood oil in different concentrations (1.25%, 2.5%, 3.75%, and 5% in acetone) was applied topically to female CD1 mice. The sandalwood oil treatment significantly decreased papilloma incidence by 67% and papilloma multiplicity by 96%. The skin of mice in the treated group appeared healthy and without any visible toxic symptoms. The authors postulated that sandalwood oil decreases the incorporation of thymidine into epidermal DNA. In vitro sandalwood oil treatment of HaCaT keratinocytes results in a blockade of cell cycle progression as well as a concentration-dependent inhibition of ultravioletinduced AP-1 activity, 2 major cellular effects known to drive skin carcinogenesis. 4 Sandalwood oil has also been found to have in vitro antiviral activity against herpes simplex viruses-1 and -2. 5 Replication of the viruses was inhibited in the presence of the oil. The oil was not virucidal and showed no cytotoxicity at the concentrations tested. With evidence of antitumor and antiviral activity, we postulated it may be useful in treating warts. The objective of our study was to examine the effectiveness of sandalwood oil as a topical treatment for common warts through a pilot open trial.
We conducted an open label trial of sandalwood oil for common warts. The study protocol was reviewed and approved by the Human Subjects Research Committee of Nationwide Children's Hospital, Columbus, Ohio. All patients were appropriately consented to participate, with parental consent for all enrolled patients and, in addition, assent by the child if 9 years of age and older.
Patients
Participants ranged in age from 6 years to adult. Participants were recruited for warts over their hands, feet, legs, or face. Subjects had not undergone any treatment for their warts for at least 60 days prior to entry into the study and did not use any other treatment during the study. 
Methodology
Ten subjects were enrolled and followed for 12 weeks. They were asked to apply a drop of sandalwood oil onto the wart area twice a day and rub gently after the application with study visits every 2 to 3 weeks until end of study. Data collected at each visit included measurements of the wart size, photograph of the warts, and any comments regarding compliance with therapy from the patient. Treatment response was determined based on review of photograph of the lesions at each study visit by raters. Recorded measurements and photos were reviewed and assessments were classified as no change; minimal change (10% to 25% reduction in size); moderate change (25% to >90% reduction in size); and resolution (no apparent wart). The reviewers rated each patient independently. At the end of the study period, each subject was then given a global rating based on the aforementioned scale of no improvement, improved, or resolved.
Safety and Tolerability Evaluation
Subjects were monitored for any reports or visible signs of irritation, erythema, itching, burning, pain, peeling, scarring, or other event occurring during the study by questioning from an investigator at the time of the study visits.
Statistical analysis used descriptive statistics (percent response to treatment).
Results
At the end of the study, 8 of 10 (80%) had complete resolution of all treated warts. The remaining 2 subjects had improvement rated as moderate (25% to >90%). There were no complaints of skin irritation, erythema, itching, pain or discomfort, or other adverse events reported (Figures 1-3 ).
Discussion
Treatments for common warts are abundant, and none demonstrate complete effectiveness. In our pilot study, we found all 10 participants had improvement with the 12-week treatment period with 80% achieving complete resolution. Compliance can also be a confounder, as treatments requiring significant effort on the part of the patient may not have good adherence. We did monitor and assure no other treatments were used during the trial. We also monitored compliance with our twice a day applications, with 9 of 10 subjects responding yes. One subject said he was not always compliant; this subject was in the moderately improved category at the end of 12 weeks.
Overall, the outcomes of this study support the use of sandalwood oil as a topical treatment of common warts caused by HPV. Subjects with complete resolution were followed for a year post study with no recurrence of their warts. In addition, sandalwood oil may exert beneficial effects on skin, reducing the likelihood of promotion of precancerous cells to actinic keratosis and skin cancer. It has potential as a treatment for genital warts and possibly for cervical cancer caused by HPV. Further randomized trials should provide additional confirmation, and additional studies may shed light on potential mechanisms of action.
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